HSB401
HSB401 is an orally active FLT3 inhibitor (IC50: 28, 5, 72, 51 nM for FLT3-WT, FLT3-D835Y, FLT3-ITD-F691L, FLT3-ITD, respectively). HSB401 downregulates FLT3 signaling and induces cell cycle arrest and apoptosis. HSB401 spares c-KIT inhibition, thereby reducing the risk of myelosuppression. HSB401 significantly suppresses tumor growth in the MV4-11 xenograft mouse model. HSB401 can be used for the research of acute myeloid leukemia.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 3022265-51-3
- Fòrmula: C26H28FN5O
- Peso molecular:445.53
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
HSB401 exhibits the GI50 value of 0.772 μM in K562 cells and 0.027 μM in MV4-11 cells[1].
HSB401 (20-500 nM, 2 h) inhibits FLT3 and its downstream signaling pathways in MV4-11 cells[1].
HSB401 (20-500 nM, 24 h) induces apoptotic cell death in MV4-11 cells, the activation of caspases 7 and 9 and the cleavage of protein PARP-1[1].
HSB401 shows nanomolar affinity to bind the kinase domain of recombinant human FLT3, with a KD comparable to that of Gilteritinib (HY-12432)[1].
HSB401 (0.001-10 μM, 72 h) exhibits antiproliferative activity against MOLM13 cells and their resistant clones comparable to that of Gilteritinib, with a selectivity ratio of 1 between resistant and parental MOLM13 cells[1].
HSB401 (20-500 nM, 2 h) reduces the FLT3 autophosphorylation at Y589/591 and attenuates FLT3 downstream signaling pathways in concentration-dependent manner in MOLM13 and Ba/F3 (FLT3-ITD) cell lines[1].
HSB401 (6.25-100 nM, 24 h) exerts FLT3-specific inhibitory effects, inducing a dose-dependent increase in G1 cells in the FLT3-dependent leukemia cell lines (MV4-11, MOLM-13 cells)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MOLM-13 cells
-
Concentration:0.001, 0.01, 0.1, 1, 10 μM
-
Incubation Time:72 h
-
Result:Exhibited comparable antiproliferative activity against parental MOLM13 cells and their resistant clones.
Showed the selectivity ratio of 1 between resistant MOLM13 cells and parental MOLM13 cells.
-
Cell Line:MOLM13 and Ba/F3 (FLT3-ITD) cell lines
-
Concentration:20, 100, 500 nM
-
Incubation Time:2 h
-
Result:Reduced the FLT3 autophosphorylation at Y589/591.
Attenuated FLT3 downstream signaling pathways in concentration-dependent manner.
-
Cell Line:MV4-11 cells
-
Concentration:20, 100, 500 nM
-
Incubation Time:24 h
-
Result:Induced apoptotic cell death in MV4-11 cells.
Induced the activation of caspases 7 and 9 and the cleavage of protein PARP-1.
Reduced the level of Mcl-1 dose-dependently.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:MV4-11-derived xenograft BALB/c nude female mice[1]
-
Dosage:30 mg/kg
-
Administration:daily oral gavage (p.o.) for 29 days
-
Result:Displayed a statistically significant tumor growth inhibition (TGI) of 80.5 %.
Induced no adverse effect on the weight of mice.
Chemical Information
-
No. CAS 3022265-51-3
-
Peso molecular 445.53
-
Fòrmula C26H28FN5O
-
SMILES
CN(C)CCNC(C(C=C1)=CC(F)=C1C(C2=C3CCCC2)=NC4=C3C(C(C)=NN5)=C5C=C4)=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)